US FDA expands use of Novartis drug for chronic skin condition

The US Food and Drug Administration has expanded the use of Novartis' drug to treat adults with ​a chronic skin condition that causes recurring itchy welts, ‌the Swiss drugmaker said on Wednesday.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。